A beloved mural depicting the late Brandy Alexander, an icon in Charlotte’s drag queen and LGBTQ communities, was painted ...

A phase 3 trial of nemvaleukin alfa in with Keytruda for patients with platinum-resistant ovarian cancer will not continue on ...

Arsh Pal has two passions in his life: his painting and helping people.On his eighth birthday, Arsh’s family gave him acrylic painting supplies and he became obsessed with the medium, producing ...

Indio has a new mural that's meaning goes beyond creative art. Artist Patrick Barwinski created the "Desi Memorial Mural," in ...

A heartfelt message from a late husband is inspiring others to take action against colon cancer. Don Refuerzo, a 46-year-old ...

Mural Oncology's stock plummeted 57% after halting the Phase 3 ARTISTRY-7 trial for nemvaleukin alfa. Click here to read an ...

For further information, call 419-332-8696 or visit the Downtown Fremont Inc. office at 315Garrison St., Fremont. Visit ...

Mural Oncology (NASDAQ:MURA – Get Free Report) had its target price lowered by equities researchers at HC Wainwright from $18 ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

Nemvaleukin alfa is an investigational engineered fusion protein composed of modified interleukin-2 (IL-2) and the high-affinity IL-2 alpha receptor chain.

Evaluation of nemvaleukin for platinum-resistant ovarian cancer will be terminated based on OS data from an interim analysis ...

A Waltham company pulled the plug on a Phase 3 cancer trial, while a different Waltham company continued its leadership ...